Integrin Beta 3 Market By Type (MSP-68, OCU-200, AC-301, C-16Y and Others), By Indication (Melanoma, Lung Cancer, Arterial Thrombosis and Others), By Distribution Channel (Hospital Pharmacies, Online Pharmacies and Others), and By Region - Market Trends, Analysis, and Forecast till 2030

Report Code: PMI466421 | Publish Date: June 2023 | No. of Pages: 192

Global Integrin Beta3 Market Trends

Growing numbers of cancer patient’s drive up demand

Global demand for androgen receptor inhibitors is predicted to rise in response to the rising incidence of lung cancer and melanoma. Throughout the forecast period, it is anticipated that changing lifestyles and other habits like smoking will increase demand for inhibitors.

Numerous clinical trials

The market for Integrin beta-3 is expanding due to the large number of drugs undergoing clinical trials that are in the pipeline and the increased commercialization by different companies. Key players are increasing their research and development efforts, which is good for the market.